Systematic review of pregnancy in women with inherited cardiomyopathies

European Journal of Heart Failure

Volumn 13, Issue 6, 2011, Pages 584-594

  Krul, Sébastien P J ^a   Van Der Smagt, Jasper J ^b   Van Den Berg, Maarten P ^c   Sollie, Krystyna M ^c   Pieper, Petronella G ^c   Van Spaendonck Zwarts, Karin Y ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Arrhythmia; DNA analysis; Genetic counselling; Heart failure; Inherited cardiomyopathy; Pregnancy

Indexed keywords

DNA;

CARDIOVASCULAR RISK; CESAREAN SECTION; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; GENETIC COUNSELING; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEFT VENTRICULAR NON COMPACTION CARDIOMYOPATHY; MATERNAL CARE; PERINATAL PERIOD; PERIPARTUM CARDIOMYOPATHY; PREGNANCY; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SYSTOLIC DYSFUNCTION; THROMBOSIS; VAGINAL DELIVERY;

CARDIOMYOPATHIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 79957840670     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr040     Document Type: Review

References (68)

1. Szekely P, Julian DG. Heart disease and pregnancy. Curr Probl Cardiol 1979;4:1-74.
2. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992;68:540-543. (Pubitemid 23001727)
3. Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol 2008;22:801-823.
4. Dawes M, Chowienczyk PJ. Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 2001;15:819-826.
5. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005;44:989-1008. (Pubitemid 41356388)
6. Jeong H. Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes. Expert Opin Drug Metab Toxicol 2010;6:689-699.
7. Siu SC, Colman JM. Heart disease and pregnancy. Heart 2001;85:710-715.
8. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104:515-521. (Pubitemid 32738118)
9. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
10. van Mook WN, Peeters L. Severe cardiac disease in pregnancy, part II: impact of congenital and acquired cardiac diseases during pregnancy. Curr Opin Crit Care 2005;11:435-448. (Pubitemid 41482699)
11. Oakley C, Child A, Jung B, Presbitero P, Tornos P, Klein W, Alonso Garcia MA, Blomstrom-Lundqvist C, de Backer G, Dargie H, Deckers J, Flather M, Hradec J, Mazzotta G, Oto A, Parkhomenko A, Silber S, Torbicki A, Trappe HJ, Dean V, Poumeyrol-Jumeau D. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-781.
12. Messina M, Biffignandi P, Ghigo E, Jeantet MG, Molinatti GM. Possible contraindication of spironolactone during pregnancy. J Endocrinol Invest 1979;2:222. (Pubitemid 9243278)
13. Alwan S, Polifka JE, Friedman JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005;73:123-130. (Pubitemid 40289535)
14. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-1188. (Pubitemid 30126607)
15. Frishman WH, Chesner M. Beta-adrenergic blockers in pregnancy. Am Heart J 1988;115:147-152. (Pubitemid 18032713)
16. Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Car-diovasc Dis 1993;36:137-178. (Pubitemid 23281634)
17. Hebbar AK, Hueston WJ. Management of common arrhythmias: Part II. Ventricular arrhythmias and arrhythmias in special populations. Am Fam Physician 2002;65: 2491-2496. (Pubitemid 34664741)
18. Joglar JA, Page RL. Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 2001;16: 40-45. (Pubitemid 32060029)
19. Adamson DL, Nelson-Piercy C. Managing palpitations and arrhythmias during pregnancy. Heart 2007;93:1630-1636. (Pubitemid 350205569)
20. Damilakis J, Theocharopoulos N, Perisinakis K, Manios E, Dimitriou P, Vardas P, Gourtsoyiannis N. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation 2001;104:893-897. (Pubitemid 32778039)
21. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003; 108:1871-1909. (Pubitemid 37303907)
22. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation 1997;96:2808-2812. (Pubitemid 27500075)
23. Vitale N, De FM, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-1641.
24. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edition). Chest 2008;133:844S-886S. (Pubitemid 351892978)
25. Cox PB, Gogarten W, Marcus MA. Maternal cardiac disease. Curr Opin Anaesthesiol 2005;18:257-262. (Pubitemid 40806678)
26. Ray P, Murphy GJ, Shutt LE. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth 2004;93:428-439. (Pubitemid 39206907)
27. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardio-myopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009; 2:253-261.
28. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999;281:650-655. (Pubitemid 29098067)
29. Christiaans I, van EK, van Langen IM, Birnie E, Bonsel GJ, Elliott PM, Wilde AA. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. Europace 2010;12:313-321.
30. Turner GM, Oakley CM, Dixon HG. Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy. Br Med J 1968;4:281-284.
31. Oakley GD, McGarry K, Limb DG, Oakley CM. Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J 1979;1:1749-1750. (Pubitemid 9203840)
32. Autore C, Conte MR, Piccininno M, Bernabo P, Bonfiglio G, Bruzzi P, Spirito P. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1864-1869. (Pubitemid 35341967)
33. Avila WS, Rossi EG, Ramires JA, Grinberg M, Bortolotto MR, Zugaib M, da Luz PL. Pregnancy in patients with heart disease: experience with 1,000 cases. Clin Cardiol 2003;26:135-142. (Pubitemid 36330863)
34. Thaman R, Varnava A, Hamid MS, Firoozi S, Sachdev B, Condon M, Gimeno JR, Murphy R, Elliott PM, McKenna WJ. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003;89:752-756. (Pubitemid 36760635)
35. Avila WS, Amaral FM, Ramires JA, Rossi EG, Grinberg M, Bortolotto MR, Mady C, Krieger JE, Zugaib M. Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. Arq Bras Cardiol 2007;88:480-485.
36. Bernstein PS, Magriples U. Cardiomyopathy in pregnancy: a retrospective study. Am J Perinatol 2001;18:163-168. (Pubitemid 32587760)
37. Grewal J, Siu SC, Ross HJ, Mason J, Balint OH, Sermer M, Colman JM, Silversides CK. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2009;55:45-52.
38. Palojoki E, Kaartinen M, Kaaja R, Reissell E, Karkkainen S, Kuusisto J, Helio T. Pregnancy and childbirth in carriers of the lamin A/C-gene mutation. Eur J Heart Fail 2010;12:630-633.
39. Bauce B, Daliento L, Frigo G, Russo G, Nava A. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol 2006;127:186-189. (Pubitemid 44192563)
40. Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ 2006;332: 1251-1255. (Pubitemid 44365417)
41. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-1084. (Pubitemid 30207690)
42. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardi-omyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Transla-tional Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-1816. (Pubitemid 43958474)
43. van Tintelen JP, van Spaendonck-Zwarts KY, van den Berg MP. Lamin A/C-related cardiac disease and pregnancy. Eur J Heart Fail 2010;12:532-534.
44. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997;30: 1512-1520. (Pubitemid 27486470)
45. Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS, Estes NA III, Marcus F, Scheinman MM. Efficacy of antiarrhythmic drugs in arrhyth-mogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol 2009;54:609-615.
46. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.
47. Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, Wessels MW, ten Cate FJ, Sijbrands EJ, Dooijes D, Majoor-Krakauer DF. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopa-thy. Circ Cardiovasc Genet 2010;3:232-239.
48. Murphy RT, Thaman R, Blanes JG, Ward D, Sevdalis E, Papra E, Kiotsekoglou A, Tome MT, Pellerin D, McKenna WJ, Elliott PM. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 2005;26: 187-192. (Pubitemid 40282788)
49. Lofiego C, Biagini E, Pasquale F, Ferlito M, Rocchi G, Perugini E, Bacchi-Reggiani L, Boriani G, Leone O, Caliskan K, ten Cate FJ, Picchio FM, Branzi A, Rapezzi C. Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart 2007;93:65-71. (Pubitemid 46094056)
50. Pantazis AA, Elliott PM. Left ventricular noncompaction. Curr Opin Cardiol 2009; 24:209-213.
51. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36: 493-500.
52. Mogensen J, Arbustini E. Restrictive cardiomyopathy. Curr Opin Cardiol 2009;24: 214-220.
53. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
54. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12: 767-778.
55. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007;118:295-303. (Pubitemid 46695762)
56. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP. Peripartum cardiomyopa-thy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169-2175.
57. Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010;121:2176-2182.
58. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM. Natural course of peripartum cardiomyopathy. Circulation 1971;44: 1053-1061.
59. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050-2055. (Pubitemid 40577899)
60. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, Hameed A, Gviazda I, Shotan A. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-1571. (Pubitemid 32479908)
61. Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002;186: 1005-1010.
62. de Souza JLJ, de Carvalho FC, Nastari L, Mady C. Left ventricular function after a new pregnancy in patients with peripartum cardiomyopathy. J Card Fail 2001;7: 30-35. (Pubitemid 32285186)
63. Fett JD, Fristoe KL, Welsh SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet 2010; 109:34-36.
64. Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardio-myopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008;199:415.e1-415.e5.
65. Sliwa K, Forster O, Zhanje F, Candy G, Kachope J, Essop R. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 2004;93:1441-3, A10. (Pubitemid 38692484)
66. van Spaendonck-Zwarts KY, van den Berg MP, van Tintelen JP. DNA analysis in inherited cardiomyopathies: current status and clinical relevance. Pacing Clin Elec-trophysiol, 2008;31(Suppl 1):S46-S49. (Pubitemid 351143777)
67. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, Helio T Keren A, McKenna WJ, Monserrat L, Pankuweit S, Perrot A, Rapezzi C, Ristic A, Seggewiss H, van LI, Tavazzi L. Genetic counselling and testing in cardi-omyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010.
68. Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America Practice Guideline. J Card Fail 2009;15:83-97.